POTOMAC, MARYLAND / ACCESS Newswire / March 17, 2025 / IGC Pharma, Inc. ("IGC Pharma" or the "Company") today announced the addition of a new trial site at BayCare's St. Anthony's Hospital in St.

The authors aim to elucidate the mechanism by which pyroptosis (through the formation of Gasdermin D (GSDMD) pores in the plasma membrane) contributes to increased release of procoagulant Tissue ...

New research from the Kennedy Institute has revealed how two important proteins, TBK1 and IKKε, play a crucial role in ...

Host cells activate cell death pathways in response to bacterial manipulation of innate immune signalling, but the molecular ...

ZyVersa Therapeutics, Inc. announced promising results from a study on its Inflammasome ASC Inhibitor IC 100, which may serve as an effective treatment for obesity-associated cardiomyopathy (OAC ...

ZyVersa Therapeutics (ZVSA) highlights newly published animal model data demonstrating that inflammasome inhibition attenuates obesity-associated cardiomyopathy, which has a 5-year survival rate ...

Harvard Medical School scientists have identified a key protein in the human immune system that drives inflammatory and autoimmune conditions when it turns against the body. The protein, Granzyme ...

A rheumatology and immunology professor has shared the 'best' kind of anti-inflammatory diet to follow which, according to research, 'reverses symptoms in eight weeks'. Speaking to ZOE Health co ...

WALTHAM, Mass. & MONTREAL--(BUSINESS WIRE)--Ventus Therapeutics, a clinical-stage biopharmaceutical company with two novel small-molecule programs entering Phase 2 development for immunological ...